Company Filing History:
Years Active: 2018
Title: The Innovations of Takashi Kangas
Introduction
Takashi Kangas is an accomplished inventor based in Shoreview, MN (US). He has made significant contributions to the field of cancer treatment through his innovative research and patents. With a total of 2 patents, Kangas is recognized for his work in enhancing the effectiveness of anti-cancer therapies.
Latest Patents
Kangas's latest patents focus on the use of soluble β-glucan in combination with various agents to affect the tumor microenvironment. The first patent discusses methods and compositions that utilize soluble β-glucan alongside immune suppression-relieving agents. This combination promotes an immunostimulatory environment, enhancing the effectiveness of anti-angiogenics and checkpoint inhibitors. The second patent relates to the use of soluble β-glucan in conjunction with anti-cancer agents, further emphasizing its role in creating a favorable environment for cancer treatment.
Career Highlights
Kangas is currently associated with Biothera Inc., where he continues to develop innovative solutions for cancer therapy. His work has been pivotal in advancing the understanding of how β-glucan can be utilized to improve treatment outcomes for patients.
Collaborations
Kangas collaborates with notable colleagues, including Nandita Bose and Keith B Gorden, to further his research and development efforts in the field of oncology.
Conclusion
Takashi Kangas is a notable inventor whose work in cancer treatment through the use of β-glucan has the potential to significantly impact patient care. His contributions to the field are invaluable and continue to pave the way for future innovations.